Bumetanide, >=98 %

Code: b3023-1g D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Inhibitor of Na+/K+/Cl- cotransporter.

Features and Benefits

This compound was developed...


en savoir plus

Votre prix
£227.00 1G
DEMANDER

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Inhibitor of Na+/K+/Cl- cotransporter.

Features and Benefits

This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

Other Notes

Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. B3023.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.

assay≥98%
formpowder
Gene Informationhuman ... SLC12A1(6557)
InChI keyMAEIEVLCKWDQJH-UHFFFAOYSA-N
InChI1S/C17H20N2O5S/c1-2-3-9-19-14-10-12(17(20)21)11-15(25(18,22)23)16(14)24-13-7-5-4-6-8-13/h4-8,10-11,19H,2-3,9H2,1H3,(H,20,21)(H2,18,22,23)
originatorRoche
Quality Level100
SMILES stringCCCCNc1cc(cc(c1Oc2ccccc2)S(N)(=O)=O)C(O)=O
Code
Description
Unité de vente
Prix annoncé
Qté
B3023-250MG
Bumetanide, >=98 %

Unité:250MG
Prix annoncé: £187.00
Source:Prix annoncé
AJOUTER
Cas Number28395-03-1
Ce produit répond aux critères suivants: